NO752837L - - Google Patents

Info

Publication number
NO752837L
NO752837L NO752837A NO752837A NO752837L NO 752837 L NO752837 L NO 752837L NO 752837 A NO752837 A NO 752837A NO 752837 A NO752837 A NO 752837A NO 752837 L NO752837 L NO 752837L
Authority
NO
Norway
Prior art keywords
compound
formula
general formula
phosphate
lower alkyl
Prior art date
Application number
NO752837A
Other languages
Norwegian (no)
Inventor
K F Burri
F Kienzle
P Rosen
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO752837L publication Critical patent/NO752837L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/117Esters of phosphoric acids with cycloaliphatic alcohols
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/113Esters of phosphoric acids with unsaturated acyclic alcohols

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

FOSFORFORBINDELSERPHOSPHORUS COMPOUNDS

Foreliggende oppfinnelse vedrorer fosforforbindelser, nemlig dienylfosfate av den generelle formel The present invention relates to phosphorus compounds, namely dienyl phosphate of the general formula

hvori og R'^betyr lavere alkyl, aryl eller benzyl og R^, R^ °<3 R^ hydrogen eller lavere alkyl, og 1,4-cyklo-addisjonsprodukter av den generelle formel wherein and R'^ means lower alkyl, aryl or benzyl and R^, R^ °<3 R^ hydrogen or lower alkyl, and 1,4-cycloaddition products of the general formula

hvori R^, R'-^R3°9R4^ar oven angitte betydning, og Z fremstiller resten til en dienofil forbindelse. wherein R^, R'-^R3°9R4^ are as defined above, and Z prepares the residue to a dienophilic compound.

I IN

Forbindelsene av formel I og V har anthelmintiske egenskaper ogThe compounds of formula I and V have anthelmintic properties and

er derfor anvendbare som anthelmintika.are therefore applicable as anthelmintics.

Uttrykket "lavere alkyl" referer seg til rettkjedede alkylgrupper med 1-5 karbonatomer. Uttrykket "aryl" referer seg til fenyl, som med lavere alkyl, halogen (fluor, klor og brom), nitrogen . eller lavere alkoksy ( med 1-5 karbonatomer) enkelt eller flere ganger kan være substituert. The term "lower alkyl" refers to straight chain alkyl groups of 1-5 carbon atoms. The term "aryl" refers to phenyl, as with lower alkyl, halogen (fluorine, chlorine and bromine), nitrogen. or lower alkoxy (with 1-5 carbon atoms) can be single or multiple substituted.

Dienylfoefat er fremstilt i formel I i s-cis-formen for enkelthets skyld, dette betyr dog ikke nodvendigvis den virkelige geometriske konformasj onen. Dienyl phophate is prepared in formula I in the s-cis form for the sake of simplicity, but this does not necessarily mean the real geometric conformation.

Foretrukne forbindelser av formel I er de hvori R og R'^betyr metyl eller etyl og R^, R^og R^fremstiller hydrogen. Spesielt foretrukket er dimetyl-)1,3-butadien-2-yl)-fosfat (eller dimetyl-l-vinylvinylfosfat), dietyl-(1,3-butadien-2-yl)-fosfat Preferred compounds of formula I are those in which R and R' are methyl or ethyl and R', R' and R' are hydrogen. Particularly preferred are dimethyl (1,3-butadiene-2-yl)-phosphate (or dimethyl-1-vinyl vinyl phosphate), diethyl (1,3-butadiene-2-yl)-phosphate

(eller dietyl-1-vinylvinylfosfat).(or diethyl-1-vinyl vinyl phosphate).

Forbindelsene av formel I og V kan fremstilles ifolge oppfinnelsen ved at man omsetter enolatet av en forbindelse av den generelle formel The compounds of formula I and V can be prepared according to the invention by reacting the enolate of a compound of the general formula

hvori R2, R3og R^har de oven angitte betydninger, med et halogenfosfat av den generelle formel in which R 2 , R 3 and R 4 have the meanings given above, with a halophosphate of the general formula

I IN

hvori R1og R'^har den oven angitte betydningin which R1 and R'^ have the meaning indicated above

og Y fremstiller klor, brom eller jod,and Y produces chlorine, bromine or iodine,

eller at man omsetter 3,4-diklorbutanon med en fosfitt av den generelle formel or that 3,4-dichlorobutanone is reacted with a phosphite of the general formula

hvori R^ har den oven angitte betydning, wherein R^ has the above meaning,

hvorved-man ved den siste reaksjon erholder en forbindelsewhereby a compound is obtained in the last reaction

av formel I, hvori R^, R^ °9 R 4 fremstiller hydrogen og R^ogof formula I, wherein R^, R^ °9 R 4 produces hydrogen and R^ and

R'-^er identiske, og at man hvis onsket omsetter en forbindelse av formel I med en dienofil forbindelse til en forbindelse av formel V. R'-^ are identical, and that, if desired, a compound of formula I is converted with a dienophilic compound into a compound of formula V.

Forbindelsene av formel I, hvori R^, R^0<3 R^fremstiller hydrogen og hvori R.^og R'^er identiske blir erholdt ved omsetning av 3,4-diklorbutanon med et fosfitt av formelen II. The compounds of formula I, wherein R^, R^0<3 R^ produces hydrogen and wherein R^^ and R'^ are identical are obtained by reacting 3,4-dichlorobutanone with a phosphite of formula II.

Eksempler på slike fosfitter er: trimetylfosfitt, trietylfosfitt, tri-(n-propyl)-fosfitt, tri-(n-butyl)-fosfitt, tri-(n-pentyl)-fosfitt, trifenylfosfitt og tribenzylfosfitt. Spesielt foretrukne fosfitter er trimetylfosfitt og trietylfosfitt. Examples of such phosphites are: trimethyl phosphite, triethyl phosphite, tri-(n-propyl) phosphite, tri-(n-butyl) phosphite, tri-(n-pentyl) phosphite, triphenyl phosphite and tribenzyl phosphite. Particularly preferred phosphites are trimethyl phosphite and triethyl phosphite.

Omsetningen av 3,4-diklorbutanonet med fosfittet av formel IIThe reaction of the 3,4-dichlorobutanone with the phosphite of formula II

ble hensiktsmessig utfort i fravær av ytterligere opplosningsmidler. Hvis onsket, kan dog også inerte organiske opplosningsmidler anvendes, som f.eks. hydrokarboner, som heksan, benzen was appropriately carried out in the absence of additional solvents. If desired, however, inert organic solvents can also be used, such as e.g. hydrocarbons, such as hexane, benzene

og tolueh, eller halogenerte hydrokarboner, som diklormetan og lignende. and toluene, or halogenated hydrocarbons, such as dichloromethane and the like.

Det ser ut til at reaksjonen går i to trinn. Det forste trinnet foregår raskt ved temperaturer på ca. 0 til ca. 5o°C, fortrinnsvis ca. 2o til ca. 3o°C, hvorved alkylkloridet R^Cl blir utviklet. The reaction appears to proceed in two steps. The first step takes place quickly at temperatures of approx. 0 to approx. 5o°C, preferably approx. 2o to approx. 3o°C, whereby the alkyl chloride R^Cl is evolved.

I det andre reaksjonstrinnet blir klorhydrogen-eliminert. Dette opptrår ved opphetningen til ca. 5o til ca. 15o°C, og blir hensiktsmessig gjennomfort ved destillasjon av reaksjonsblandingen, fortrinnsvis under redusert trykk. Man erholder på denne måte et sluttprodukt av formel I, hvori R^, R3og R^betyr hydrogen. In the second reaction step, hydrogen chloride is eliminated. This occurs when heated to approx. 5o to approx. 15o°C, and is conveniently carried out by distillation of the reaction mixture, preferably under reduced pressure. In this way, a final product of formula I is obtained, in which R 1 , R 3 and R 3 are hydrogen.

i For å fremme elimineringen av klorhydrogenet under destillasjonen, tilsetter man hensiktsmessig en liten mengde (eksempelvis mindre enn 1 mol-%) av en Lewis-syre, eksempelvis aluminiumklorid. i In order to promote the elimination of the hydrogen chloride during the distillation, a small amount (for example less than 1 mol%) of a Lewis acid, for example aluminum chloride, is suitably added.

For å forhindre polymerisasjonen av dienet av formel I under destillasjonen er det hensiktsmessig å tilsette en liten mengde (eksempelvis 1 mol-% eller mindre) av en polymerisasjons-inhibitor, eksempelvis hydrokinon. In order to prevent the polymerization of the diene of formula I during the distillation, it is appropriate to add a small amount (for example 1 mol% or less) of a polymerization inhibitor, for example hydroquinone.

Fremstillingen av dienylfosfater fra 3,4-diklorbutanon og fosfitt er å betrakte som uventet med henblikk derpå at den samme reaksjonen under anvendelse av 3,4-dibrombutanon som bekjent kun gir metyl-vinyl-keton ( J.P. Schroeder, et al., J. Org, The production of dienyl phosphates from 3,4-dichlorobutanone and phosphite is to be regarded as unexpected in view of the fact that the same reaction using 3,4-dibromobutanone as known only gives methyl-vinyl-ketone (J.P. Schroeder, et al., J. Org,

Chem. 35, 3181 (197o)). Chem. 35, 3181 (1970)).

Det samlede antall av forbindelser som omfattes av formel I kan'fremstilles utfra et konjugert keton av formelen' The total number of compounds covered by formula I can be prepared from a conjugated ketone of the formula

og det på den måte som ovenfor allerede er utfort, ved omsetning av et enolat av én forbindelse av formel III med et halogenfosfat av formel IV. and that in the manner already explained above, by reacting an enolate of one compound of formula III with a halogenophosphate of formula IV.

Enolatet av en forbindelse av formel III, dvs. en forbindelseThe enolate of a compound of formula III, i.e. a compound

av formelenof the formula

hvori R2, R3og R4har den oven angitte betydning in which R2, R3 and R4 have the meaning indicated above

og M<+>fremstiller natrium-, kalium- eller litiumionet, kan fremstilles derved at omsetter forbindelsen av formel III and M<+>represents the sodium, potassium or lithium ion, may be prepared by reacting the compound of formula III

met en sterk, organisk, opploslig alkalimetallamidbase i et inert organisk opplosningsmiddel ved lav temperatur. Foretrukne baser er alkalimetallakylamid og alkalimetallcykloalkylamid som eksempelvis litium-N-cykloheksyl-N-isopropyamid,lltium-cyklo-leksyl-amid og alkalimetallsilylamid, som natrium-bis(trimetyl-silyl)-amidet. For gjennomforingen av denne omsetningen egnede inerte organiske opplosningsmidler er eksempelvis organiske etere, som dietyleteren, dioksan og tetrahydrofuran, samt hydrokarboner, som heksan og heptan og lignende. met a strong, organic, soluble alkali metal amide base in an inert organic solvent at low temperature. Preferred bases are alkali metal alkylamide and alkali metal cycloalkylamide such as lithium N-cyclohexyl-N-isopropyamide, lithium cyclohexyl amide and alkali metal silylamide, such as sodium bis(trimethylsilyl)amide. Suitable inert organic solvents for carrying out this reaction are, for example, organic ethers, such as diethyl ether, dioxane and tetrahydrofuran, as well as hydrocarbons, such as hexane and heptane and the like.

Det således erholdte enolatet blir så omsatt med et halogenfosfat av formelen IV. Såvel dannelsen av enolatet som den derpå fSigende reaksjonen med halogenfosfatet kan hensiktsmessig gjennomfores ved redusert temperatur eksempelvis ved ca. -80- ca. -2o°C. The enolate thus obtained is then reacted with a halogen phosphate of the formula IV. Both the formation of the enolate and the subsequent reaction with the halogen phosphate can conveniently be carried out at a reduced temperature, for example at approx. -80- approx. -2o°C.

Et spesielt foretrukket temperaturområde ligger mellom ca. -65 til ca. -75°C. A particularly preferred temperature range is between approx. -65 to approx. -75°C.

Etter vanlig opparbeidelse blir produktet av formel I isolertAfter the usual work-up, the product of formula I is isolated

og renset. En spesielt foretrukket rensningsmetode består i destillasjon under redusert trykk. and cleaned. A particularly preferred purification method consists in distillation under reduced pressure.

Som eksempler på forbindelsen av formel I kan nevnes: dimetyl-(1,3-butadien-2-yl)-fosfat As examples of the compound of formula I can be mentioned: dimethyl-(1,3-butadiene-2-yl)-phosphate

dietyl-(1,3-butadien-2-yl)-fosfat diethyl-(1,3-butadiene-2-yl)-phosphate

dimetyl-(1,3-pentadien-3-yl)-fosfat dimethyl-(1,3-pentadien-3-yl)-phosphate

dietyl-(1,3-pentadien-3-yl)-fosfat diethyl-(1,3-pentadien-3-yl)-phosphate

dimetyl-(1,3-pentadien-2-yl)-fosfat dimethyl-(1,3-pentadien-2-yl)-phosphate

dietyl-(1,3-pentadien-2-yl)-fosfat diethyl-(1,3-pentadien-2-yl)-phosphate

dimetyl-(3-metyl-l,3—butadien-2-yl)-fosfat dietyl-(3-metyl-l,3-butadien-2-yl)-fosfat dimetyl-(3-metyl-l,3-pentadien-2-yl)-fosfat dimethyl-(3-methyl-1,3-butadiene-2-yl)-phosphate diethyl-(3-methyl-1,3-butadiene-2-yl)-phosphate dimethyl-(3-methyl-1,3-pentadiene -2-yl)-phosphate

* dietyl-(3-metyl-l,3-pentadien-2-yl)-fosfat dimetyl-(3-metyl-l,3-pentadien-3-yl)-fosfat dietyl-(2-metyl-l,3-pentadien-3-yl)-fosfat dimetyl-(3-etyl-l,3-heksadien-2-yl)-fosfat dietyl-(3-etyl-l,3-heksadien-2-yl)-fosfat dimetyl-(2-etyl-l,3-heksadien-3-yl)-fosfat dietyl-(2-etyl-l,3-heksadien-3-yl)-fosfat dimetyl-(4-metyl-3,5-decadien-5-yl)-fosfat dietyl-(5-etyl-3,5-nonadien-4-yl)-fosfat * diethyl-(3-methyl-1,3-pentadien-2-yl)-phosphate dimethyl-(3-methyl-1,3-pentadien-3-yl)-phosphate diethyl-(2-methyl-1,3- pentadien-3-yl)-phosphate dimethyl-(3-ethyl-1,3-hexadien-2-yl)-phosphate diethyl-(3-ethyl-1,3-hexadien-2-yl)-phosphate dimethyl-(2 -ethyl-1,3-hexadien-3-yl)-phosphate diethyl-(2-ethyl-1,3-hexadien-3-yl)-phosphate dimethyl-(4-methyl-3,5-decadien-5-yl )-phosphate diethyl-(5-ethyl-3,5-nonadien-4-yl)-phosphate

dimetyl-(4-metyl-2,4-decadien-3-yl)-fosfat dietyl-(4-propyl-3,5-nonadien-5-yl)-fosfat. dimethyl-(4-methyl-2,4-decadien-3-yl)-phosphate diethyl-(4-propyl-3,5-nonadien-5-yl)-phosphate.

Forbindelsene av formel I er substituerte diener og inngår lett Diels-Alder-reaksjon med dienofile forbindelser under dannelse The compounds of formula I are substituted dienes and readily undergo Diels-Alder reaction with dienophilic compounds to form

av 1,4-cykloaddisjonsprodukter (enolfosfater) av formel V.of 1,4-cycloaddition products (enol phosphates) of formula V.

Under en dienofil forbindelser er i det folgende å forstå en umettet organisk forbindelse, som med en konjugert dien inngår en 1,4-cykloaddisjonsreaksjon. De fleste dionefile forbindelser har en ikke-aromatisk umettet binding.(dobbeltbinding eller tredobbeltbinding), som.er direkte substituert med minst en elektronegativ gruppe. Eksempler på slike dienofile forbindelser er: nitriler, f.eks. tetracyanetylen og akrylnitril, aldehyder f.eks. krotonaldehyd og akrolein, syrer, f.eks. akrylsyre, kanel-syre, maleinsyre og fumarsyre, ester, f.eks. etylakrylat, dimetylmaleat, dimétylfumarat, dietyl-acetylendikarboksylat, dietylazodikarboksylat, anhydrider, f.eks. amaleinsyreanhydrid og citraconsyreanhydrid, imider, f.eks. N-fenylmaleinimid, 4-fenyl-1,2,4-triazolin-3,5-dion og p-fenylazomaleinanil, nitroso-forbindelser, f.eks.nitrosobenzen, nitrogenforbindelser, f.eks. p-nitrostyrol og 1-nitropropen, ketoner, f.eks. metyl-vinyl-keton og lignende. In the following, a dienophilic compound is understood to mean an unsaturated organic compound, which enters into a 1,4-cycloaddition reaction with a conjugated diene. Most dionephilic compounds have a non-aromatic unsaturated bond (double bond or triple bond), which is directly substituted with at least one electronegative group. Examples of such dienophilic compounds are: nitriles, e.g. tetracyanethylene and acrylonitrile, aldehydes e.g. crotonaldehyde and acrolein, acids, e.g. acrylic acid, cinnamic acid, maleic acid and fumaric acid, ester, e.g. ethyl acrylate, dimethyl maleate, dimethyl fumarate, diethyl acetylene dicarboxylate, diethyl azodicarboxylate, anhydrides, e.g. maleic anhydride and citraconic anhydride, imides, e.g. N-phenylmaleimide, 4-phenyl-1,2,4-triazoline-3,5-dione and p-phenylazomaleinanil, nitroso compounds, e.g. nitrosobenzene, nitrogen compounds, e.g. p-nitrostyrene and 1-nitropropene, ketones, e.g. methyl vinyl ketone and the like.

i in

Fremstillingen av Diels-Alderaddukte fra forbindelser av formel I foregår på vanlig måte for slike Diels-Alderreaksjoner. Man The preparation of Diels-Alder adducts from compounds of formula I takes place in the usual way for such Diels-Alder reactions. Mon

kan herved arbeide i fravær av et opplosningsmiddel ellercan thereby work in the absence of a solvent or

i nærvær av et inert organisk opplosningsmiddel, hvorved kan nevnes som eksempler på inerte organiske opplosningsmidler: hydrokarboner, som heksan, heptan, benzen og tolaen, halogenerte hydrokarboner, som diklormetan, organiske etere, som dietyleter, tetrahydrofuran og dioksan og lignende. Diels-Alderreaksjonen kan gjennomfores innen et bredt temperaturområde, eksempelvis'in the presence of an inert organic solvent, whereby examples of inert organic solvents may be mentioned: hydrocarbons, such as hexane, heptane, benzene and tolaene, halogenated hydrocarbons, such as dichloromethane, organic ethers, such as diethyl ether, tetrahydrofuran and dioxane and the like. The Diels-Alder reaction can be carried out within a wide temperature range, for example'

mellom c* a. 0 og ca. +15o oC. Et foretrukket temperaturområde ligger mellom ca. 2o og ca. 7o°C. between c* a. 0 and approx. +15o oC. A preferred temperature range is between approx. 2o and approx. 7o°C.

Som ovenfor nevnt er dienylfosfatet av.formel I anvendbar som anthelmintika. Ytterligere har også enolfosfatet av formel V en anthelmintisk virkning. Forbindelsene av formel I er dermed også anvendbare som mellomprodukter for fremstillingen av forbindelsene av formel V. As mentioned above, the dienyl phosphate of formula I can be used as an anthelmintic. Furthermore, the enol phosphate of formula V also has an anthelmintic effect. The compounds of formula I are thus also usable as intermediates for the preparation of the compounds of formula V.

Spesielt er forbindelsene ifolge oppfinnelsen anvendbare for bekjempning av Ascaris suum-infeksjoner, hvorved de blir hensiktsmessig administrert oralt ( tilsetning på o,l% til f6r.). In particular, the compounds according to the invention are useful for combating Ascaris suum infections, whereby they are suitably administered orally (addition of o.1% to f6r.).

Forbindelsene av formel I er også, som ovenfor vist, anvendbare som reagensier for Diels-Alderreaksjoner. The compounds of formula I are also, as shown above, useful as reagents for Diels-Alder reactions.

Ytterligere tjener forbindelsene av formel I som verdifulle monomere, hvilke kan polymeriseres enten med seg selv eller med andre monomere, hvorved man erholder komplekse polymermolekyler med et stort antall anvendelsesmuligheter, eksempelvis forbindelser som er anvendbare som brannfarehemmere. Furthermore, the compounds of formula I serve as valuable monomers, which can be polymerized either with themselves or with other monomers, thereby obtaining complex polymer molecules with a large number of application possibilities, for example compounds that are useful as fire hazard inhibitors.

EKSEMPEL 1EXAMPLE 1

Man kjoler 166 g trietylfosfitt i et isbad og tilsetter deretter 14o g 3,4-diklorbutanon. Blandingen blir rort i 2 timer ved 0° og så i 2o timer ved romtemperatur. Etter at man har tilsatt o,5 g hydrokinon og o,5 g aluminiumklorid, blir blandingen destillert under redusert trykk, hvorved man erholder 34,4 g rent dietyl-(1,3-butadien-2-yl)-fosfat-hemihydrat, hvilket koker ved 91-92°/2 mmHg. 166 g of triethyl phosphite are soaked in an ice bath and then 140 g of 3,4-dichlorobutanone are added. The mixture is stirred for 2 hours at 0° and then for 20 hours at room temperature. After 0.5 g of hydroquinone and 0.5 g of aluminum chloride have been added, the mixture is distilled under reduced pressure, whereby 34.4 g of pure diethyl-(1,3-butadiene-2-yl)-phosphate hemihydrate is obtained, which boils at 91-92°/2 mmHg.

Det i framgangsmåten ovenfor anvendte 3,4-diklorbutanon kan erholdes som folger: The 3,4-dichlorobutanone used in the above procedure can be obtained as follows:

klor ichlorine i

Man. leder/en opplosning av 14o g metyl-vinyl-keton i 6oo ml kloroform under iskjoling. Etter at 142 g klor var blitt absorbert, blir det dannede kloroformet avdampet (badtemperatur 35°) hvorved 29o g lett forurenset 3,4-diklorbutanon erholdes, hvilket kan anvendes uten noen videre rensing. Mon. lead/a solution of 140 g of methyl vinyl ketone in 600 ml of chloroform under ice-cooling. After 142 g of chlorine had been absorbed, the chloroform formed is evaporated (bath temperature 35°), whereby 290 g of slightly contaminated 3,4-dichlorobutanone is obtained, which can be used without any further purification.

EKS EMPEL 2EKS EMPEL 2

Man omsetter 28,6 g trimetylfosfitt med 32 g 3,4-diklorbutanon analogt til eksempel 1. Etter destillasjonen erholder man rent dimetyl-(1,3-butadien-2-yl)-fosfat, hvilket koker ved 79-83°/l,5 mmHg. 28.6 g of trimethylphosphite is reacted with 32 g of 3,4-dichlorobutanone analogously to example 1. After the distillation, pure dimethyl-(1,3-butadiene-2-yl)-phosphate is obtained, which boils at 79-83°/l .5mmHg.

UV 22o nm (6 1652o) i metanol.UV 22o nm (6 1652o) in methanol.

E KSEMPEL 3EXAMPLE 3

En opplosning av 2,15 g dietyl-(1,3-butadien-2-yl)-fosfatA solution of 2.15 g of diethyl-(1,3-butadiene-2-yl)-phosphate

i lo ml tetrahydrofuran tilsetter man 1,28 g tetracyanetylen under en nitrogenatmosfære. Man lar den erholdte gule opplosningen stå ved romtemperatur i 2 dager og damper så inn. Den tilbakeblivende sirup blir tatt opp i etylacetat, man tilsetter petroleter til det inntrår formorkelse og lar blandingen stå i 5 dager ved 0°. Etter filtrering erholder man 2,lo g 1,1,2,2-tetracyan-4-(o,o-dietylfosforyloksy)-cykloheksen med et smp. på 97-98°. Etter omkrystallisering fra en blanding av etylacetat og petroleter erholder man den rene substansen i form av lange prismer og korte flak med et smp. på 98°. 1.28 g of tetracyanethylene are added to 10 ml of tetrahydrofuran under a nitrogen atmosphere. The yellow solution obtained is allowed to stand at room temperature for 2 days and then evaporated. The remaining syrup is taken up in ethyl acetate, petroleum ether is added until darkening occurs and the mixture is allowed to stand for 5 days at 0°. After filtration, 2.log g 1,1,2,2-tetracyano-4-(o,o-diethylphosphoryloxy)-cyclohexene is obtained with a m.p. at 97-98°. After recrystallization from a mixture of ethyl acetate and petroleum ether, the pure substance is obtained in the form of long prisms and short flakes with a m.p. at 98°.

IR (petrolatum): maks 1665, 126o og lo45 cm<-1>.IR (petrolatum): max 1665, 126o and lo45 cm<-1>.

i in

NMR (CDC1 ), T* : 8,61 (triplett, 6H), 6,69 (multiplett, 4H), 5,75 (kvintett, 4H), 4,12 (multiplett, 1H). NMR (CDCl ), T* : 8.61 (triplet, 6H), 6.69 (multiplet, 4H), 5.75 (quintet, 4H), 4.12 (multiplet, 1H).

E KSEMPEL 4EXAMPLE 4

En blanding av o,98 g maleinsyreanhydrid og 1,78 g dimetyl-(1,3-butadien-2-yl)-fosfat i 5o ml benzen ble rort ved romtemperatur i 2o timer. Den etter inndampingen erholdte seigtflytende masse ble krystallisert fra etylacetat/petroleter, hvorved man erholder o,81o g 4-(o,o-dimetylfosforyloksy)-cyklo-heks-4-éh-cis-l,2-karboksylsyreanhydrid med et smp. på A mixture of 0.98 g of maleic anhydride and 1.78 g of dimethyl-(1,3-butadiene-2-yl)-phosphate in 50 ml of benzene was stirred at room temperature for 20 hours. The viscous mass obtained after evaporation was crystallized from ethyl acetate/petroleum ether, thereby obtaining 0.810 g of 4-(o,o-dimethylphosphoryloxy)-cyclohex-4-éh-cis-1,2-carboxylic acid anhydride with a m.p. on

71-72°. Etter omkrystallisering fra det samme opplosningsmiddel-system erholder man prismer, hvilke smelter ved 73-74°. 71-72°. After recrystallization from the same solvent system, prisms are obtained, which melt at 73-74°.

IR (petrolatum): 185o, 1785, 167o, 1275 og lo45 cm<-1>.IR (petrolatum): 185o, 1785, 167o, 1275 and 1045 cm<-1>.

EKSEMP EL 5EXAMPLE EL 5

En opplosning på 3,24 g nitrosobenzen i 15o ml metylenklorid blir tilsatt 6,25 g dietyl-(1,3-butadien-2-yl)-fosfat. To a solution of 3.24 g of nitrosobenzene in 150 ml of methylene chloride is added 6.25 g of diethyl-(1,3-butadiene-2-yl)-phosphate.

Man lar blandingen stå i 2o timer ved romtemperatur og damper deretter inn. Det tilbakeblivende råproduktet blir renset på en kiselgelsoyle og eluert med etylacetat/petroleter (1:2) hvorved man erholder 7,1 g svakt farget 2-fenyl-4-(o,o-dietyl-fosforyloksy)-3,6-dihydro-2H-l,2-oksazin. The mixture is allowed to stand for 20 hours at room temperature and then evaporated. The remaining crude product is purified on a silica gel column and eluted with ethyl acetate/petroleum ether (1:2), whereby 7.1 g of faintly colored 2-phenyl-4-(o,o-diethyl-phosphoryloxy)-3,6-dihydro- 2H-1,2-oxazine.

UV (etanol) : 24o (E 788o) , 282 nm (£, 85o).UV (ethanol) : 24o (E 788o) , 282 nm (£, 85o).

NMR (CDCl-j)<1>^: 6,15 (s), 5,5o (m) , 4,25 (m) .NMR (CDCl-j)<1>^: 6.15 (s), 5.50 (m), 4.25 (m).

EKSEMPEL 6EXAMPLE 6

1,78 g dimetyl-(1,3-butadien-2-yl)-fosfat blir opplost i 3o ml metyl-vinyl-keton og oppløsningen blir rort i 2o timer ved 65°C 1.78 g of dimethyl-(1,3-butadiene-2-yl)-phosphate are dissolved in 30 ml of methyl vinyl ketone and the solution is stirred for 20 hours at 65°C

i en nitrogenatmosfære. Heretter blir overskuddet av metyl-vinyl-keton avdampet og man erholder 3,60g av et råprodukt som blir renset ved soylekromatografi. in a nitrogen atmosphere. The excess of methyl vinyl ketone is then evaporated and 3.60 g of a crude product is obtained which is purified by soil chromatography.

Acyltoppenes stilling i NMR-spekteret viser at produktet erThe position of the acyl peaks in the NMR spectrum shows that the product is

en blanding av isomerer, og nemlig av l-acetyl-3-(o,o-dimetyl-fosforyloksy)-cykloheks-3-en og l-acetyl-4-(o,o-dimetylfosforyl-oksy) -cykloheks-3-en. a mixture of isomers, namely of l-acetyl-3-(o,o-dimethyl-phosphoryloxy)-cyclohex-3-ene and l-acetyl-4-(o,o-dimethylphosphoryl-oxy)-cyclohex-3- one.

E KSEMPEL 7EXAMPLE 7

Man lar en opplosning av ekvivalente mengder av dietyl-(1,3-butadien-2-yl)-fosfat og 4-fenyl-1,2,4-triazolin-3,5-dion- A solution of equivalent amounts of diethyl-(1,3-butadiene-2-yl)-phosphate and 4-phenyl-1,2,4-triazoline-3,5-dione-

stå i lo til 2o timer ved romtemperatur. Heretter blir opplosnings-middelet fjernet og resten blir krystallisert fra benzen/heksan, hvorved man erholder fargelose krystaller av 2-fenyl-6-(o,o-di-etylfosforyloksy) -2, 3,5, 8-tetrahydro-lH-s-triazolo-,/I, 2a_7 pyridazin-1,3-dion med et smp. på 84-85°C. let stand for 2o hours at room temperature. The solvent is then removed and the residue is crystallized from benzene/hexane, whereby colorless crystals of 2-phenyl-6-(o,o-di-ethylphosphoryloxy)-2,3,5,8-tetrahydro-lH-s are obtained -triazolo-,/I, 2a_7 pyridazine-1,3-dione with a m.p. at 84-85°C.

E KSEMPEL» 8E XAMPLE" 8

En opplosning på 31 g N-cykloheksyl-N-isopropylamid i 4oo ml tetrahyi rofuran blir kjolt til -7o°. Under roring blir opp-løsningen tilsatt o,22 mol n-butyllitium i heksan dråpevis i lopet av 5 min. Heretter tilsetter man 14 g metyl-vinyl-keton i lopet av 2o min.og deretter 37,8 g dietylklorfosfat i lopet av lo min. Så lar man opplosningen stå i 9o min. ved -7o°,stå hvorved man lar den oppvarmes til romtemperatur. Heretter blir fortynnet med metylenklorid og deretter vasket med 5%'ig vandig natriui hydrokarbonatopplosning, 1 N vandig saltsyre og lo%'ig vandig natriumkloridopplosning. Den organiske fasen blir heretter torket, inndampet og resten destillert, hvorved man erholder 22-25 g dietyl-(1,3-butadien-2-yl)-fosfat, hvilket koker ved 7 4°/o,5 mmHg. A solution of 31 g of N-cyclohexyl-N-isopropylamide in 400 ml of tetrahydrofuran is cooled to -70°. While stirring, 0.22 mol of n-butyllithium in hexane is added dropwise over the course of 5 minutes. 14 g of methyl vinyl ketone are then added over the course of 20 minutes and then 37.8 g of diethyl chlorophosphate over the course of 10 minutes. The solution is then left to stand for 90 minutes. at -7o°, stand where it is allowed to warm up to room temperature. It is then diluted with methylene chloride and then washed with 5% aqueous sodium bicarbonate solution, 1 N aqueous hydrochloric acid and 10% aqueous sodium chloride solution. The organic phase is then dried, evaporated and the residue distilled, whereby 22-25 g of diethyl-(1,3-butadiene-2-yl)-phosphate are obtained, which boils at 7 4°/o.5 mmHg.

Claims (1)

1. Fremgangsmåte for fremstilling av dienylfosfater av den generelle formel 1. Process for the preparation of dienyl phosphates of the general formula hvori R-^ og R1 ^ betyr lavere alkyl, aryl eller benzyl og R^, R^ 0<3 R4 betyr hydrogen og lavere alkyl, og av 1,4-cyklo-addisjonsprodukter herav av den generelle formel wherein R-^ and R1^ mean lower alkyl, aryl or benzyl and R^, R^ 0<3 R4 means hydrogen and lower alkyl, and of 1,4-cycloaddition products thereof of the general formula "hvori R'^ , R'^/ R2' R3°^ R4 ^ar ^en oven angitte betydning og Z er en rest av en dienofil forbindelse, karakterisert ved at man omsetter enolatet av en forbindelse av den generelle formel "wherein R'^ , R'^/ R2' R3°^ R4 ^are ^one specified above meaning and Z is a residue of a dienophilic compound, characterized by converting the enolate of a compound of the general formula hvori 1*2, R^ og R4 har den oven angitte betydning, med et halogenfosfat av den generelle formel ;hvori R^ og R <1>^ har den oven angitte betydning, og Y betyr klor, brom eller jod, eller at man omsetter 3,4-diklorbutanon med en fosfitt av den generelle formel ;hvori R^ har den oven angitte betydning, hvorved man erholder ved den siste reaksjonen en forbindelse av formel I, hvori R2/ R-^° g R4 fremstiller hydrogen og R^ og R1 ^ er identisk, og at man om onsket omsetter en forbindelse av formel I med en dienofil forbindelse til en forbindelse av formel V.;2. Fremgangsmåte ifolge krav 1, karakterisert ved at man anvender 3,4-klorbutanon eller en forbindelse av formel IV, hvori R^ , R'1 fremstiller metyl eller etyl, som utgangsmaterialer.;3. Fremgangsmåte ifolge krav 1 eller 2, karakterisert ved at man anvender et utgangsmate-riale, hvori R2 , R^ og R4 fremstiller hydrogen.;4. Fremgangsmåte ifolge krav 1, 2 eller 3, karakterisert ved at man omsetter 3,4-diklorbutanon med en forbindelse av formel II fost ved ca-, o til ca. • 5o o C og sener1 e under oppvarming til ca. 5o til 15o oC.;5. Fremgangsmåte ifolge krav 4, karakterisert ved at man anvender er begynnelsestemperatur på ca. 2o til ca. 3o°C.;6. tFremgangsmåte ifolge krav 4, karakterisert ved at man utforer oppvarmingen som destillasjon.;7. Fremgangsmåte ifolge ett av kravene 4-6, karakterisert ved at man gjennomforer reaksjonen i fravær av et ytterligere opplosningsmiddel.;8. Fremgangsmåte ifolge ett av kravene 1-3, karakterisert ved at gjennomforer omsetningen av et enolat av en forbindelse av formel III med et halogenfosfat av formel IV ved lav temperatur, fortrinnsvis mellom ca. -2o og ca. -8o°C, spesielt mellom ca. -65 og -75°C.;9. Fremgangsmåte ifolge krav 8, karakterisert ved at man anvender litiumenolatet som enolatet av en forbindelse av formel III.;10 . Fremgangsmåte for fremstilling av farmasoytiske preparater med anthelmetisk virkning, karakterisert ved at man blander en dienylfosfat av den generelle formel ;hvori R^ og R1 betyr lavere alkyl, aryl eller benzyl og R2 , R3 og R^ betyr hydrogen eller lavere alkyl, I eller et 1,4-cyklo-addisjonsprodukt herav av den generelle formel ;hvori Rj^, R'^/ R2' R3°9 R4 *iar ^en oven angitte betydning, og Z fremstiller resten av dienofil forbindelse, med et farmazoytisk fordragelig bærermateriale.wherein 1*2, R^ and R4 have the above meaning, with a halogenophosphate of the general formula ; in which R^ and R<1>^ have the meaning indicated above, and Y means chlorine, bromine or iodine, or that one reacts 3,4-dichlorobutanone with a phosphite of the general formula; in which R^ has the above meaning, whereby one obtains in the last reaction a compound of formula I, in which R2/R-^° g R4 produces hydrogen and R^ and R1^ are identical, and that, if desired, one reacts a compound of formula I with a dienophilic compound to a compound of formula V.;2. Process according to claim 1, characterized by using 3,4-chlorobutanone or a compound of formula IV, in which R^ , R' 1 produce methyl or ethyl, as starting materials.;3. Process according to claim 1 or 2, characterized in that a starting material is used, in which R 2 , R 1 and R 4 produce hydrogen.; 4. Method according to claim 1, 2 or 3, characterized in that 3,4-dichlorobutanone is reacted with a compound of formula II fost at ca-, o to ca. • 5o o C and sener1 e during heating to approx. 5o to 15o oC.;5. Method according to claim 4, characterized in that one uses an initial temperature of approx. 2o to approx. 3o°C.; 6. tProcedure according to claim 4, characterized in that the heating is carried out as distillation.;7. Method according to one of claims 4-6, characterized in that the reaction is carried out in the absence of an additional solvent.;8. Method according to one of claims 1-3, characterized in that carrying out the reaction of an enolate of a compound of formula III with a halogen phosphate of formula IV at a low temperature, preferably between approx. -2o and approx. -8o°C, especially between approx. -65 and -75°C.;9. Process according to claim 8, characterized in that the lithium enolate is used as the enolate of a compound of formula III.;10. Process for the production of pharmaceutical preparations with anthelmintic action, characterized by mixing a dienyl phosphate of the general formula; in which R^ and R1 mean lower alkyl, aryl or benzyl and R2 , R3 and R^ mean hydrogen or lower alkyl, In or a 1,4-cycloaddition product thereof of the general formula ;in which Rj^, R'^/ R2' R3°9 R4 *iar ^a meaning given above, and Z prepares the remainder of the dienophilic compound, with a pharmaceutically acceptable carrier material. 11. Farmasoytisk preparat med anthelmintisk virkning, karakterisert ved at det inneholder et dienylfosfat av den generelle formel 11. Pharmaceutical preparation with anthelmintic action, characterized in that it contains a dienyl phosphate of the general formula hvori R^ og R'^ betyr lavere alkyl, aryl eller benzyl og R2 , R3 og R^ betry hydrogen eller lavere alkyl, eller et 1,4-cyklo-addisjonsprodukt herav av den generelle formel wherein R 1 and R 1 are lower alkyl, aryl or benzyl and R 2 , R 3 and R 3 are hydrogen or lower alkyl, or a 1,4-cycloaddition product thereof of the general formula hvori R^ , R,1 ^, R^' R3°9 R4 ^ar den oven angitte betydning og Z fremstiller resten av en dienofil forbindelse, sammen med et farmasoytisk fordragelig bærermateriale. ' 12. Forbindelser av den generelle formel wherein R 1 , R 1 , R 1 , R 3 , R 4 , are as defined above and Z forms the residue of a dienophilic compound, together with a pharmaceutically acceptable carrier material. ' 12. Compounds of the general formula hvori R-^ og R^ betyr lavere alkyl, aryl eller benzyl og R2 , R3 og R4 betyr hydrogen eller lavere alkyl, og 1,4-cyklo-addisjonsprodukter herav av den generelle formel in which R-^ and R^ mean lower alkyl, aryl or benzyl and R 2 , R 3 and R 4 mean hydrogen or lower alkyl, and 1,4-cycloaddition products thereof of the general formula hvori R^ , R'-^ R3°9 R4 har ^en ovenfor angitte betydning og Z betyr resten av en dienofil forbindelse.in which R^ , R'-^ R3°9 R4 have ^an above stated meaning and Z means the residue of a dienophilic compound. 13. Forbindelser ifolge krav 12, hvori R^ og R'^ betyr metyl eller etyl.13. Compounds according to claim 12, in which R^ and R'^ mean methyl or ethyl. 14. Forbindelser ifolge kravene 12. eller 13, hvori R2 , R^ og R^ betyr hydrogen.14. Compounds according to claims 12 or 13, in which R 2 , R 1 and R 2 are hydrogen. 15. Dimetyl-(1,3-butadien-2-yl)-fosfat.15. Dimethyl-(1,3-butadiene-2-yl)-phosphate. 16. Dietyl-(1,3-butadien-2-yl)-fosfat.16. Diethyl-(1,3-butadiene-2-yl)-phosphate. 17. 1,1,2,2-tetracyan-4-(o,o-dietylfosforyloksy)-cyklo-heks-4-en.17. 1,1,2,2-Tetracyano-4-(o,o-diethylphosphoryloxy)-cyclohex-4-ene. 18. 4-(o,o-dimetylfosforyloksy)-cykloheks-4-en-cis-l, 2-karboksylsyreanhydrid.18. 4-(o,o-dimethylphosphoryloxy)-cyclohex-4-ene-cis-1,2-carboxylic acid anhydride. 19. 2-fenyl-4-(o,o-dietylfosforyloksy)-3,6-dihydro-2H-1,2-oksazin.19. 2-Phenyl-4-(o,o-diethylphosphoryloxy)-3,6-dihydro-2H-1,2-oxazine. 20 . l-acetyl-3-(o,o-dimetylfosforyloksy)-cykloheks-3-en.20 . 1-acetyl-3-(o,o-dimethylphosphoryloxy)-cyclohex-3-ene. 21. l-acetyl-4-(o,o-dimetylfosforyloksy)-cykloheks-3-en.21. 1-acetyl-4-(o,o-dimethylphosphoryloxy)-cyclohex-3-ene. 22. 2-fenyl-6-(o,o-dietylfosforyloksy)-2,3,5,8-tetrahydro-lH-s-triazolo-/l,2a/-pyridazin-l,3-dion.22. 2-Phenyl-6-(o,o-diethylphosphoryloxy)-2,3,5,8-tetrahydro-1H-s-triazolo-[1,2a]-pyridazine-1,3-dione.
NO752837A 1974-08-15 1975-08-14 NO752837L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/497,598 US3933948A (en) 1974-08-15 1974-08-15 Dienylphosphates

Publications (1)

Publication Number Publication Date
NO752837L true NO752837L (en) 1976-02-17

Family

ID=23977520

Family Applications (1)

Application Number Title Priority Date Filing Date
NO752837A NO752837L (en) 1974-08-15 1975-08-14

Country Status (20)

Country Link
US (1) US3933948A (en)
JP (1) JPS5143725A (en)
AR (1) AR210861A1 (en)
AT (1) AT342076B (en)
BE (1) BE832423A (en)
DD (1) DD123476A5 (en)
DE (1) DE2535514A1 (en)
DK (1) DK368575A (en)
ES (1) ES440252A1 (en)
FI (1) FI752292A (en)
FR (1) FR2288525A1 (en)
GB (1) GB1477278A (en)
IE (1) IE42048B1 (en)
IL (1) IL47817A0 (en)
LU (1) LU73201A1 (en)
NL (1) NL7509762A (en)
NO (1) NO752837L (en)
NZ (1) NZ178249A (en)
SE (1) SE7509042L (en)
ZA (1) ZA754766B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3001519A1 (en) * 1980-01-17 1981-07-30 Bayer Ag, 5090 Leverkusen ENDOPARASICICIDAL AGENTS

Also Published As

Publication number Publication date
LU73201A1 (en) 1977-04-13
ES440252A1 (en) 1977-03-01
DK368575A (en) 1976-02-16
IE42048L (en) 1976-02-15
AT342076B (en) 1978-03-10
DE2535514A1 (en) 1976-03-04
IE42048B1 (en) 1980-05-21
BE832423A (en) 1976-02-16
NZ178249A (en) 1978-03-06
US3933948A (en) 1976-01-20
NL7509762A (en) 1976-02-17
GB1477278A (en) 1977-06-22
AR210861A1 (en) 1977-09-30
FI752292A (en) 1976-02-16
AU8364975A (en) 1977-02-10
FR2288525B1 (en) 1979-09-14
ZA754766B (en) 1976-03-31
SE7509042L (en) 1976-02-16
IL47817A0 (en) 1975-10-15
FR2288525A1 (en) 1976-05-21
JPS5143725A (en) 1976-04-14
ATA635975A (en) 1977-07-15
DD123476A5 (en) 1976-12-20

Similar Documents

Publication Publication Date Title
Konno et al. Facile syntheses of various per-or polyfluoroalkylated internal acetylene derivatives
US3022305A (en) Process for preparing pyridazine derivatives and novel fluorine-containing pyridazine derivatives
Duerr et al. Benzocyclobutenylidene-cycloadditions, reactivity, and multiplicity
US7687632B2 (en) Process for the preparation of pyridine derivatives
House et al. Stereochemical aspects of the Claisen rearrangement of allyl vinyl ethers
Ruf et al. Organophosphorus Compounds. Part 151: Synthesis and Reactivity of a Novel Isophosphinoline Derivative
NO752837L (en)
Jensen et al. Isomers for Electrophilic Studies. Resolution of 2-Bromomercuributane, Assignment of Configuration and Cleavage of the Enantiomorphs by Bromine1-13
US4937308A (en) Preparation of alkyl O,O-dialkyl-γ-phosphonotiglates
US4025584A (en) 1-Acetyl-3(4)-(dihydrocarbylphosphoryloxy)-cyclohex-3-enes
US3978172A (en) Process for the preparation of dienylphosphates
HU186374B (en) Process for producing alkyl-substituted hydrocarbon derivatives
US3978171A (en) Process for the preparation of dienylphosphates
Clarke et al. Boron-nitrogen compounds. 113. Boron-halogenated pyrazaboles
US4109086A (en) 3,6-dihydro-2h-1,2-oxazines
Paquette et al. Synthesis and reactivity patterns of meso-and dl-bistriquinacene. Efficient route to the diastereomeric bivalvanes
Kočevar et al. Heterocycles. CI. Syntheses and Isomerizations of Some Allylthio Nitrogen Heterocycles
Galiullina et al. Chemistry of diazocarbonyl compounds: XXX. Development of a synthetic approach to pyridazine structure via wittig reaction of fluoroalkyl-containing diazo keto esters
US4342704A (en) Process for the preparation of 1,1-dichloroalkenes
Carroll et al. Benzylation and Benzoylation of Methyl Phenacyl Sulfone
US4440947A (en) Preparation of substituted alpha-halogeno-propionic acids and their derivatives
US4876393A (en) β-fluoroacyl-β-halovinyl alkyl ethers
Teunissen et al. Diels-Alder Reactions of Trichlorophosphaethene
NITTA et al. Reaction of phosphorus oxyacid esters with p-toluenesulfonic acid
CA1076593A (en) MANUFACTURE OF .beta.-BROMOALKYLSULFONES AND .beta.-BROMOALKENYLSULFONES